Olfactory Acuity in Chronic Migraine: A Cross-Sectional Study. by Whiting, Alexander C et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Neurology Faculty Papers Department of Neurology
11-11-2014
Olfactory Acuity in Chronic Migraine: A Cross-
Sectional Study.
Alexander C Whiting
Michael J. Marmura
Thomas Jefferson University, michael.marmura@jefferson.edu
Sarah E Hegarty
Thomas Jefferson University, sarah.hegarty@jefferson.edu
Scott W. Keith
Thomas Jefferson University, Clinical Pharmacology and Experimental Therapeutics, Scott.Keith@jefferson.edu
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/neurologyfp
Part of the Neurology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Neurology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Whiting, Alexander C; Marmura, Michael J.; Hegarty, Sarah E; and Keith, Scott W., "Olfactory
Acuity in Chronic Migraine: A Cross-Sectional Study." (2014). Department of Neurology Faculty
Papers. Paper 77.
http://jdc.jefferson.edu/neurologyfp/77
 1 
Olfactory Acuity in Chronic Migraine: a Cross-sectional Study 
ABSTRACT: 
Objective: To measure olfactory acuity in chronic migraine subjects, at baseline and on 
migraine days, and compare to age and sex-matched controls.  
Background: Olfactory impairment is common in neurological disorders. While smell 
hypersensitivity has been established with chronic migraine, olfactory acuity has not been 
well studied.  
Methods: We recruited 50 subjects with chronic migraine from the Jefferson Headache 
Center and 50 age and sex-matched controls. Using the University of Pennsylvania Smell 
Identification Test (UPSIT), a validated test of olfaction, olfactory acuity was measured 
at baseline and during a migraine for subjects, and compared to controls at baseline and at 
home 2 weeks later. All subjects were additionally screened for odor sensitivity and 
allodynia.   
Results: The mean UPSIT score for migraine subjects was 34.5 on non-migraine days 
and 34.7 on migraine days [mean difference = -0.4, 95% CI (-1.3, 0.6) p = 0.45]. Controls 
had a mean of 35.9 and 36.1 for each test day [mean difference = -0.1, 95% CI (-0.9, 0.7) 
p = 0.87].  On average, migraineurs performed worse than their matched control 
counterparts in both test sittings [test 1: p = 0.047; test 2: p = 0.01].  The great majority of 
subjects were allodynic (42/50) compared with only 9 of 50 controls, and the majority of 
subjects (41/50) found more than 1 listed odor to be bothersome, compared with only 
10/50 controls. On non-migraine days 18/48 chronic migraine subjects had abnormal 
olfaction and on migraine days 14/42 had abnormal olfaction, compared with only 9/50 
controls who had abnormal olfaction on their first UPSIT.  
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Conclusions: While chronic migraine patients do not appear to have a significant change 
in olfactory acuity between migrainous and non-migrainous periods, they do appear to be 
more likely to have abnormal olfactory acuity at baseline compared to age and sex-
matched controls.  
INTRODUCTION: 
Patients with chronic migraine (CM) often display significant disability, as well 
hypersensitivity to specific stimuli such as light and sound.1 Hypersensitivity to sensory 
stimuli such light and sound are both diagnostic features of migraine,2 but migraine 
patients are also much more likely to be bothered by odors than other persons. In fact, 
osmophobia may be a more specific symptom in differentiating migraine from other 
headache disorders.3, 4 Discomfort due to olfactory stimuli is most prominent during acute 
migraine, but may persist between attacks.5  
Olfactory impairment is a common symptom of other neurologic disorders such as 
schizophrenia and Parkinson’s disease. This may be related to damage of dopaminergic, 
serotonergic and cholinergic systems.6, 7 It is possible that olfactory hypersensitivity in 
CM patients is related to this dopaminergic dysfunction. While olfactory sensitivity has 
been demonstrated in patients with migraine, olfactory acuity in episodic migraine 
subjects in between attacks is similar to age and sex-matched controls with a standardized 
testing of olfaction.8 This includes our previous study of olfaction using the University of 
Pennsylvania Smell Identification Test (UPSIT).9  In these episodic migraine subjects, 
olfactory acuity decreased in many patients during acute migraine and even after 
successful acute treatment. Based on these results, we hypothesized that CM patients 
would have greater olfactory deficits on both migraine days and less severe days.  
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METHODS: 
We recruited 50 patients from the Jefferson Headache Center clinic from June – August 
2011 meeting criteria for CM ages 18-65 as defined by the International Classification of 
Headache Disorders (ICHD-2R).10 As indicated by the diagnosis, subjects were required 
to have at least 8 migraine days a  month (or days with acute migraine medication use) 
and at least 15 days a month of headache. Additionally, the subjects had to meet the 
migraine criteria of having headaches accompanied by either nausea and/or vomiting or 
both photophobia and phonophobia. We obtained formal approval for this study from the 
Institutional Review Board at Thomas Jefferson University and all subjects and controls 
provided informed consent. We excluded subjects or controls with a history of significant 
headache trauma, nasal or sinus disease, and neurologic disorders such as Parkinson 
disease, dementia or multiple sclerosis. We excluded patients regularly taking sedating 
medications during acute attacks, such as opioids. Given that subjects had to take the 
UPSIT on both more severe migraine days and non-migraine days, we included patients 
with some fluctuation between migraine and non-migraine days. Subjects who met the 
inclusion criteria completed a questionnaire to determine disease diagnosis and history, 
attain demographic information, and verify medications. No particular education level 
was obtained. We used the questionnaire to determine the patients’ subjective olfactory 
characteristics, asking subjects how they would describe their smell function during a 
migraine day using the forced answers “improves”, “stays the same”, or “gets worse”. 
We asked patients if they found one or more odors bothersome using a forced answer 
question bank, recording the patient as being sensitive to odors if they answered “most 
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always” or “always” for any of the odors presented. We established the presence of 
allodynia during migraine using a validated questionnaire which screens for the presence 
of unpleasant sensations of skin in response to routine activities such as combing hair, 
wearing clothes or heat and cold exposure.11 
After completing the questionnaire, subjects and controls took the UPSIT, a standardized, 
validated test for olfaction.12 The test involves 40 odorants embedded in “scratch and 
sniff” microcapsules, each with a four answer forced choice question about the identity of 
the odorant. A score of 35 or greater is considered normal for women, and a score of 34 
or greater is considered normal in men.12 A change in UPSIT score of greater than 3 
points is considered clinically significant for the purposes of this study. Subjects were 
then given a second UPSIT test to take home with them, to be taken 2 weeks later during 
a migraine at home. If a subject took the UPSIT on the initial visit during a migraine 
attack, they were required to repeat the UPSIT during a non-migraine day at least 2 
weeks after the initial visit. The subjects were asked to take the non-migraine day test on 
a day when they were completely free of any symptoms of their migraines or headaches, 
and the timing of this was left to the determination of the subject. Subjects were required 
to mail or drop off the second test at the Jefferson Headache Center.  
For comparison, 50 controls were recruited from the hospital, community, and friends 
and family of patients. Controls were age (± 2 years) and sex-matched and had no history 
of migraine. Controls were excluded if they displayed any disability from headache as 
determined by score of greater than “0” on the Migraine Disability Assessment (MIDAS) 
Questionnaire.13 Controls completed a similar questionnaire as given to the subjects about 
olfactory sensitivity, function and allodynia, and then completed an UPSIT test in the 
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Jefferson Headache Center. Controls were then given an additional UPSIT test, which 
they completed at home 2 weeks later and sent back to the clinic.  
Statistical Analysis: 
Baseline characteristics were compared between matched pairs of subjects and controls 
using McNemar's or Bowker's tests of symmetry for categorical data, as appropriate, and 
paired t-tests for continuous data.  Similarly, paired t-tests were used to compare matched 
subject and controls scores and scores from between test sittings. All tests are two-tailed 
with statistical significance set at α = 0.05. Analyses were performed in SAS 9.3 (SAS 
Institute Inc., Cary, NC). 
The number of subjects was determined before the study based on previous studies using 
UPSIT in various neurological disorders which assumed an effect size of 3 points for the 
parameter of group differences in olfaction, and based on the funding available for this 
study. 
RESULTS: 
We recruited 50 CM subjects and age and sex-matched controls, although one of the 10 
male cases, a 43 year-old, was matched to a 42 year-old female control. CM subjects had 
a mean age of 42 with a range of 18-63, while controls had a mean age of 41.7 with a 
range of 20-64. The great majority of subjects were allodynic (42/50) compared with only 
9 of 50 controls, and the majority of subjects (41/50) found more than 1 listed odor to be 
bothersome, compared with only 10/50 controls. Table 1 lists demographic features of the 
two groups. A majority (28/50) of subjects had aura, but 22/50 did not. Visual aura was 
the most common type. Twenty-two subjects predicted increased olfactory acuity during 
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migraine days, while only 4 predicted decreased olfaction and the remainder anticipated 
no change or did not respond. 
All controls and 48/50 subjects took the UPSIT at the initial visit. Forty of the 50 CM 
subjects completed the UPSIT twice as did 47/50 controls. The mean UPSIT score for 
migraine subjects was 34.5 on non-migraine days and 34.7 on migraine days [mean 
difference = -0.4, 95% CI (-1.3, 0.6) p = 0.45]. Controls had a mean of 35.9 and 36.1 for 
each test day [mean difference = -0.1, 95% CI (-0.9, 0.7) p = 0.87].  On average, 
migraineurs performed slightly worse than their matched control counterparts in both test 
sittings [test 1: mean difference = -1.5 (-3.0, 0.0) p = 0.047; test 2: mean difference = -1.5 
(-2.7, -0.3) p = 0.01].  On non-migraine days 18/48 CM subjects had abnormal olfaction 
and on migraine days 14/42 had abnormal olfaction (McNemar’s test, p = 1.00). Nine of 
50 controls had abnormal olfaction on the first UPSIT, and 10 of 47 had abnormal scores 
on follow-up testing. Four CM subjects had a decrease of olfaction of greater than 3 
points on migraine compared to non-migraine days, while two had a greater than 3 point 
increase in UPSIT scores on migraine days. Two controls had a decreased UPSIT score 
of greater than 3 points on the second test and one had an increase of greater than 5 
points. (Table 2) Of the 8 non-allodynic subjects with CM, 1 had abnormal olfaction and 
1 did not complete the during-migraine UPSIT. 
CONCLUSION: 
Olfaction and sensitivity to odors is a significant problem in migraine, but olfactory 
acuity is generally normal in persons with episodic migraine. However, there is 
increasing evidence that for some persons olfactory acuity is affected by migraine. Hirsh, 
in a study predating existing migraine classification, found that about 18% of migraine 
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subjects were hyposmic or anosmic based on Pyridine odor threshold testing.14 Although 
our previously described study found that persons with episodic migraine had normal 
olfaction, a significant number had decreased olfaction during acute attacks.9 In this study 
of CM subjects, a much larger proportion had abnormal olfaction but interestingly the 
difference between migraine and non-migraine days was not significant.  
When considering a change of greater than 3 points to be statistically significant, 4 
patients with CM had significantly lower scores during migraine, and 2 had improved 
scores. In CM subjects, their olfactory acuity does not appear to change on migraine days 
of increased severity. This lack of change in olfaction suggests a more ingrained problem, 
and may correlate with central sensitization. The majority of CM subjects in this study 
had allodynia (42/50, 84%) but no patient without allodynia had abnormal olfaction. This 
suggests poor olfaction could be a relatively specific measure for central sensitization in 
migraine, much like in degenerative diseases. 
Increases in parasympathetic tone, which can manifest as tearing, swelling or congestion 
during migraine, is associated with engorgement of nasal turbinates.15 Fluctuations in 
nasal engorgement are an overall indicator of autonomic tone16 and correlate with 
measures such as rapid-eye movement sleep patterns17 and cognitive abilities18. It is 
possible that CM produces these changes in autonomic tone, resulting in decreased ability 
of odorants to successfully reach smell receptors, which would have negatively affected 
performance on the UPSIT.  
Abnormal olfaction in CM could be related to the known phenomenon of olfactory 
distortions19 related to migraine. Functional neuroimaging data in chronic pain states that 
demonstrate changes in activation of basal ganglia structures with loss of dopaminergic 
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input and decreased connectivity to the prefrontal cortex20. This relates to another 
interesting issue, which is each patient’s personal sense of olfactory acuity during acute 
migraine days in CM. Among CM subjects a significant minority (22/50, 44%) reported 
improved olfaction on migraine days, while only 2 patients (8%) felt their sense of smell 
worsened and the majority reported no change (26/50, 52%). In our patients with episodic 
migraine, subjects who reported improvement in olfactory acuity during migraine did not 
actually improve. In CM subjects the results were mixed with 10 patients correctly 
predicting improved olfaction and 7 with lower scores during migraine. This difference 
was not statistically significant but was a contrast with our episodic migraine group. 
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Table 1. Descriptive summary of group characteristics. 
  Migraineurs Controls  
  (n = 50) (n = 50) p 
Age, mean (range) 42.0 (18-63) 41.7 (20-64) 0.16 
Sex, n (%) 
 
0.32 
Female 40 (80.0) 41 (82.0)  
Male 10 (20.0) 9 (18.0)  
Race, n (%)     0.90 
White 46 (92.0) 41 (82.0)  
Black 1 (2.0) 3 (6.0)  
Asian 1 (2.0) 3 (6.0)  
Hispanic 2 (4.0) 3 (6.0)  
Height (in inches), mean + std 66.0 + 3.85 66.0 + 4.00 0.97 
Weight (in lbs), mean + std 163 + 34.9 175 + 45.3 1.00 
BMI, mean + std 26.3 + 4.74 28.3 + 7.78 0.13 
Allodynia, n (%)    <0.01 
Yes 42 (84.0) 9 (18.0)  
No 8 (16.0) 41 (82.0)  
 
  Migraineurs Controls  
  (n = 50) (n = 50) p 
Odors Bothersome, n (%)     <0.01 
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Yes 41 (82.0) 10 (20.0)  
No 9 (18.0) 40 (80.0)  
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Table 2. Olfaction summary of outcomes 
  Migraineurs Controls 
Paired 
Difference 
(Migraine-
Control) 
  (n = 50) (n= 50) Mean (95% CI) 
Non-migraine day (CM) 
or baseline (control) score   
 
mean 34.5 35.9 -1.5 (-3.0, 0.0) 
Abnormal, % 18/48, (37.5%) 9/50, (18.0%) p = 0.047 
Migraine Day or 2nd 
UPSIT Score   
 
mean 34.7 36.1 -1.5 (-2.7, -0.3) 
abnormal, % 14/42, (33.3%) 10/47, (21.3%) p = 0.01 
Test Difference (2nd - 1st) 
Mean (95% CI) 
-0.4 (-1.3, 0.6) -0.1 (-0.9, 0.7)  
p = 0.45 p = 0.87  
 
